clinical trials

Genomics and GSK to integrate polygenic risk scores into trials
Clinical Trials Arena
Wed, 05/1/24 - 11:00 am
genomics
GSK
polygenic risk
clinical trials
As AI proliferates in pharma, regulators look to catch up in clinical trials
Pharma Voice
Wed, 05/1/24 - 09:27 am
FDA
clinical trials
artificial intelligence
Trials to watch: Four ALS drugs to keep an eye on
Clinical Trials Arena
Tue, 04/30/24 - 06:34 pm
ALS
clinical trials
Calico Life Sciences
AbbVie
ABBV-CLS-7262
AL-S Pharma
AP-101
Rapa Therapeutics
RAPA-501
Clene
CNMAu-8
Eli Lilly’s growth drivers, Verzenio and Jardiance, suffer clinical setbacks
Fierce Pharma
Tue, 04/30/24 - 11:20 am
Eli Lilly
Jardiance
Verzenio
clinical trials
AIM ImmunoTech reports progress in pancreatic cancer drug trial
Clinical Trials Arena
Tue, 04/30/24 - 08:34 am
AIM ImmunoTech
clinical trials
Ampligen
Imfinzi
pancreatic cancer
As BMS announces major cuts, its Karuna deal looks poised to drive growth
Pharma Voice
Tue, 04/30/24 - 08:29 am
Karuna Therapeutics
schizophrenia
Bristol Myers Squibb
clinical trials
KarXT
Prime editing comes of age as FDA clears human trials
Pharmaphorum
Tue, 04/30/24 - 08:28 am
Prime Medicine
prime editing
FDA
clinical trials
J&J-Partnered Addex Fails Phase II Epilepsy Study, Mulls Future of Candidate
BioSpace
Mon, 04/29/24 - 10:56 pm
Addex Therapeutics
JNJ
ADX71149
epilepsy
clinical trials
Investigator-led trial of Lilly’s merestinib in solid tumours terminated
Clinical Trials Arena
Mon, 04/29/24 - 11:24 am
Eli Lilly
merestinib
clinical trials
solid tumors
Key opinion leaders on GLP-1 receptor agonist clinical trial design
Clinical Trials Arena
Fri, 04/26/24 - 11:41 am
clinical trials
GLP-1 agonist
type 2 diabetes
obesity
CureVac initiates H5N1 avian influenza vaccine study
Clinical Trials Arena
Thu, 04/25/24 - 11:35 am
CureVac
GSK
vaccines
H5N1
clinical trials
Alkermes begins Phase II trial of ALKS 2680 for narcolepsy type 1
Clinical Trials Arena
Thu, 04/25/24 - 11:26 am
Alkermes
clinical trials
ALKS 2680
narcolepsy
Neurocrine-Takeda med reduces depression severity in phase 2, though analysts ask for more data detail
Fierce Biotech
Tue, 04/23/24 - 09:42 pm
Neurocrine Biosciences
clinical trials
Takeda
major depressive disorder
Savitri
Inside J&J’s strategy to de-gender clinical trials
Pharma Voice
Tue, 04/23/24 - 10:33 am
clinical trials
LGBTQ+
clinical trial diversity
JNJ
With $75m cash injection, SynOx plans ph3 rare tumour trial
Pharmaphorum
Mon, 04/22/24 - 11:33 am
SynOx Therapeutics
funding
tenosynovial giant cell tumors
clinical trials
AAN 2024: Pharma Two B’s P2B001 shows promise in early PD
Clinical Trials Arena
Sun, 04/21/24 - 10:48 pm
AAN
Pharma Two B
P2B001
Parkinson's Disease
clinical trials
AbbVie touts Rinvoq win in giant cell arteritis, potentially teeing up another label expansion
Fierce Pharma
Thu, 04/18/24 - 11:15 am
AbbVie
Rinvoq
clinical trials
giant cell arteritis
Sage Axes Parkinson’s Program for Dalzanemdor After Phase II Flop
BioSpace
Wed, 04/17/24 - 11:23 am
SAGE Therapeutics
clinical trials
Parkinson's Disease
dalzanemdor
Arrowhead's plozasiran could reach $700M-plus in sales by 2032, meet major unmet need in dyslipidemia: GlobalData
Fierce Pharma
Tue, 04/16/24 - 10:05 pm
Arrowhead Pharmaceuticals
clinical trials
RNAi
plozasiran
dyslipidemia
Ukraine was pharma’s ‘darling’ of clinical trials. As war drags on, will the industry come back?
Pharma Voice
Tue, 04/16/24 - 11:17 am
Ukraine
clinical trials

Pages